ALIKE. The report also focuses on thorny issues. According to the report, the key problems in India include barriers to LICENSING and technology transfer, strict registration requirements, limited framework for the PROTECTION of bio-pharmaceutical IP rights, patentability requirements outside international standards, lengthy pre-grant opposition proceedings and PREVIOUSLY used compulsory licensing for commercial and non-emergency situations. The index ranks countries based on 45 indicators covering patent, trademark, copyright and trade SECRETS protection.